A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

Novel approach designed to address dysregulated RNA splicing events that drive tumor growth and disease progression across ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Pharos Systems International, the leader in PrintOps, is proud to announce that it has successfully completed its System and Organization Controls (SOC) 2® Type I and II examinations. This independent ...

Merck and Eisai announced termination of a phase III trial of pembrolizumab plus lenvatinib (Lenvima) and transarterial chemoembolization (TACE) for unresectable liver cancer after an interim analysis ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced an ...

Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced results from new research presented at Obesity Week 2025 demonstrating the ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.

Long-lasting fatigue, unexplained fevers, strange bruising, or swollen lymph nodes are signals that should not be ignored, as ...

Mumbai: The Lokmanya Tilak Municipal General Hospital (LTMGH) in Sion is set to expand its Bone Marrow Transplant (BMT) ...